Royal DSM, a Dutch multinational life and materials sciences company, on Wednesday reported growing net sales in 2013. Net sales grew by 5 percent to 9.62 billion euros (13.22 billion U.S. dollars) and EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) rose by 18 percent to 1.31 billion euros. DSM also recorded a total net profit of 271 million euros, compared to 278 million euros in 2012. "We achieved significant strategic progress in 2013, also demonstrated by an 18 percent increase in full year EBITDA and strong cash generation," DSM CEO Feike Sijbesma said in a press release.